ESTRO 2022 - Abstract Book

S968

Abstract book

ESTRO 2022

Compared to WBRT(historical data), SRS performed with VMAT appear to improve survival. The majority of the patients with brain metastases still have a poor prognosis, but selected patients gained improved survival. Patients with PS ≥ 2 have doubtful gain of SRS in terms of survival, but SRS may be effective as treatment of symptoms.

Table 1 Baseline Characteristics

Table 2 Median survival and Hazard Ratios